Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-152302

Director acquired 15,000 shares (option exercise)

  • Director gave up 13,483 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BRENNAN MURRAY Director 2016-11-25 Option exercise +15,000 $6.49 $97,350 59,951 D
BRENNAN MURRAY Director 2016-11-25 Shares withheld for taxes −13,483 $7.22 $97,347 46,468 D
Derivatives
BRENNAN MURRAY Director 2016-11-25 Option exercise · Stock Option (Right to Buy) −15,000 0 D
Loading xslF345X03/doc4.xml…